Cargando…

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs

SIMPLE SUMMARY: Breast cancer screening is associated with benefits, such as mortality reduction and improved quality of life, and harms, such as false-positive results, overdiagnoses, and costs. Novel screen tests could be considered to reduce the harms and increase the benefits of screening. Liqui...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Poort, Esmée K. J., van Ravesteyn, Nicolien T., van den Broek, Jeroen J., de Koning, Harry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220983/ https://www.ncbi.nlm.nih.gov/pubmed/35740615 http://dx.doi.org/10.3390/cancers14122951

Ejemplares similares

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
por: Zielonke, Nadine, et al.
Publicado: (2021)

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)

Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation
por: Arrospide, Arantzazu, et al.
Publicado: (2015)

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
por: de Gelder, Rianne, et al.
Publicado: (2011)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History
por: van den Broek, Jeroen J, et al.
Publicado: (2020)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age
por: Burnside, Elizabeth S., et al.
Publicado: (2017)

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
por: Zielonke, Nadine, et al.
Publicado: (2023)

Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands
por: Brouwers, Rutger W. M., et al.
Publicado: (2021)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Age ranges in breast cancer screening: simulated scenarios and analysis of benefits and harms
por: Pinto-Carbó, M, et al.
Publicado: (2022)

Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis
por: Arrospide, Arantzazu, et al.
Publicado: (2016)

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy
por: Groenewoud, J H, et al.
Publicado: (2004)

The prevalence and correlates of self-harm in pregnant women with psychotic disorder and bipolar disorder
por: Taylor, Clare L., et al.
Publicado: (2016)

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue
por: Geuzinge, H Amarens, et al.
Publicado: (2021)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2016)

Estimates of benefits and harms of prophylactic use of aspirin in the general population
por: Cuzick, J., et al.
Publicado: (2015)

Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female population
por: Clarijs, Marloes E., et al.
Publicado: (2022)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Modeling the natural history of ductal carcinoma in situ based on population data
por: Chootipongchaivat, Sarocha, et al.
Publicado: (2020)

Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis
por: Yakusheva, Olga, et al.
Publicado: (2022)

Cost-benefit Analysis of Cochlear Implants: A Societal Perspective
por: Neve, Olaf M., et al.
Publicado: (2021)

Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
por: Birkó, Zsuzsanna, et al.
Publicado: (2020)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

Analysis of clinical benefit, harms, and cost-effectiveness of screening women for abdominal aortic aneurysm
por: Sweeting, Michael J, et al.
Publicado: (2018)

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria
por: Jahn, Beate, et al.
Publicado: (2019)

Systematic review of reporting benefits and harms of surgical interventions in randomized clinical trials
por: Stubenrouch, F. E., et al.
Publicado: (2020)

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening
por: Sankatsing, Valérie D. V., et al.
Publicado: (2018)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
por: Jansen, Erik E. L., et al.
Publicado: (2022)

In-hospital costs of an admission for adhesive small bowel obstruction
por: Krielen, Pepijn, et al.
Publicado: (2016)

Centrifugation affects the purity of liquid biopsy‐based tumor biomarkers
por: Rikkert, Linda G., et al.
Publicado: (2018)

Perioperative Hyperoxyphobia: Justified or Not? Benefits and Harms of Hyperoxia during Surgery
por: Weenink, Robert P., et al.
Publicado: (2020)

Exploring the Potential of Personalized Dietary Advice for Health Improvement in Motivated Individuals With Premetabolic Syndrome: Pretest-Posttest Study
por: van der Haar, Sandra, et al.
Publicado: (2021)

Liquid biopsy: state of reproductive medicine and beyond
por: Schobers, Gaby, et al.
Publicado: (2021)

Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled Analysis
por: Baboudjian, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uj0e4tm7l276aj7cmr2sqh30ic